Terashima, T.; Kido, H.; Takata, N.; Hayashi, T.; Seki, A.; Nakagawa, H.; Nio, K.; Toyama, T.; Iida, N.; Yamada, S.;
et al. Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib. Cancers 2025, 17, 278.
https://doi.org/10.3390/cancers17020278
AMA Style
Terashima T, Kido H, Takata N, Hayashi T, Seki A, Nakagawa H, Nio K, Toyama T, Iida N, Yamada S,
et al. Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib. Cancers. 2025; 17(2):278.
https://doi.org/10.3390/cancers17020278
Chicago/Turabian Style
Terashima, Takeshi, Hidenori Kido, Noboru Takata, Tomoyuki Hayashi, Akihiro Seki, Hidetoshi Nakagawa, Kouki Nio, Tadashi Toyama, Noriho Iida, Shinya Yamada,
and et al. 2025. "Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib" Cancers 17, no. 2: 278.
https://doi.org/10.3390/cancers17020278
APA Style
Terashima, T., Kido, H., Takata, N., Hayashi, T., Seki, A., Nakagawa, H., Nio, K., Toyama, T., Iida, N., Yamada, S., Shimakami, T., Takatori, H., Arai, K., Yamashita, T., Mizukoshi, E., & Yamashita, T.
(2025). Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with Lenvatinib. Cancers, 17(2), 278.
https://doi.org/10.3390/cancers17020278
